Stefan Zielonka | Associate Director, Protein Engineering And Antibody Technologies
Merck Healthcare KGaA

Stefan Zielonka, Associate Director, Protein Engineering And Antibody Technologies, Merck Healthcare KGaA

Stefan received his PhD in 2015 from the Technische Universität of Darmstadt, Germany, where he worked in the Group of Harald Kolmar in the field of protein engineering of non-canonical antibodies. During his PhD he spent some time at Scripps Institute, La Jolla (USA) working in the lab of Vaughn Smider on ultra-long CDR-H3 cow antibodies. After his Post Doc at Sanofi, Stefan joined Merck KGaA (EMD Serono) in 2016 as Senior Scientist. At the moment, he works as Associate Director at Merck KGaA, Germany, in the Department Protein Engineering and Antibody Technologies (PEAT).


Festival of Biologics Day 1 @ 14:40

Protein Engineering for efficient NK cell redirection

Festival of Biologics Day 2 @ 11:40

Engineering of mono- and bispecific cattle-derived ultralong CDR-H3 antibodies

last published: 30/Jun/22 09:37 GMT

back to speakers